Global Hemodialysis Vascular Grafts market, which accrued nearly 310 (USD Million) in 2019, is set to record the CAGR of nearly 5.2% over the period from 2020 to 2026
The global Hemodialysis Vascular Grafts market, which accrued nearly 310 (USD Million) in 2019, is set to record the CAGR of nearly 5.2% over the period from 2020 to 2026. The report offers assessment and analysis of the Hemodialysis Vascular Grafts market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million).
Hemodialysis vascular access dysfunctioning is a key reason for illness in the patients having hemodialysis and it also contributes notably towards total end-phase renal disorder expenses. This has resulted in huge demand for hemodialysis vascular grafts. Moreover, rise in the occurrence of kidney ailments, acceptance of bio-engineered vascular grafts, and product innovations have raised the product penetration in healthcare sector globally in the recent years. Furthermore, less availability of kidney donors has resulted in patients opting for hemodialysis, thereby steering the demand for hemodialysis vascular grafts.
Market Growth Dynamics
A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe. In addition to this, patients prefer hemodialysis methods over kidney transplantations due to the huge costs and this will create huge demand for the cost-effective vascular grafts. Apparently, these medical devices facilitate the proper blood flow, thereby ensuring accessibility of huge amount of blood required for performing hemodialysis. This will steer the business growth over the years ahead.
Moreover, due to complications involved due to use of synthetic arteriovenous access grafts during hemodialysis, the demand for biological vascular grafts is gaining traction in hemodialysis as it reduces probabilities of getting infection as well as low chances of rejection. This will create new growth avenues for the market over the years to come. Apparently, improvement in healthcare infrastructure facilities witnessed in the emerging economies will unravel new horizons of growth for hemodialysis vascular grafts industry during the estimated timeline.
North American Market To Amass Huge Returns Over 2020-2026
The growth of the industry in North America during the forecast timespan is owing to huge healthcare spending along with massive utilization of tissue engineered vascular grafts as well as biological vascular grafts during hemodialysis in countries like the U.S. and Canada. Apart from this, rise in the number of patients suffering from chronic renal ailments will enlarge the market scope in the region over the coming years.
Key players leveraging the market growth are InnAVasc Medical, Inc., C. R. Bard, Inc., CryoLife, Inc., W.L. Gore & Associates, LeMaitre Vascular, Inc., Merit Medical Systems, Terumo Medical Corporation, Getinge AB, Vascular Genesis, Inc., and Proteon Therapeutics, Inc.
The global hemodialysis vascular grafts market is segmented as follows:
By Raw Material
A prominent awareness about the advantages of using vascular grafts during hemodialysis procedures for patients with kidney disorders will drive the market growth over the estimated timeframe.
The CAGR of the industry is expected to be nearly 5.2% during the forecast timeline.
North America will contribute remarkably towards the global market share over the estimated timeline.